Literature DB >> 24964274

Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cells.

Joel S Schneider1, Xin Cheng, Qingshi Zhao, Chingiz Underbayev, J Patrick Gonzalez, Elizabeth S Raveche, Diego Fraidenraich, Andreas S Ivessa.   

Abstract

According to the endosymbiotic hypothesis, the precursor of mitochondria invaded the precursor of eukaryotic cells, a process that began roughly 2 billion years ago. Since then, the majority of the genetic material translocated from the mitochondria to the nucleus, where now almost all mitochondrial proteins are expressed. Only a tiny amount of DNA remained in the mitochondria, known as mitochondrial DNA (mtDNA). In this study, we report that the transfer of mtDNA fragments to the nucleus of pluripotent stem cells is still ongoing. We show by in situ hybridization and agarose DNA two-dimensional gel technique that induced pluripotent stem (iPS) cells contain high levels of mtDNA in the nucleus. We found that a large proportion of the accumulated mtDNA sequences appear to be extrachromosomal. Accumulation of mtDNA in the nucleus is present not only in the iPS cells, but also in embryonic stem (ES) cells. However upon differentiation, the level of mtDNA in the nuclei of iPS and ES cells is substantially reduced. This reversible accumulation of mtDNA in the nucleus supports the notion that the nuclear copy number of mtDNA sequences may provide a novel mechanism by which chromosomal DNA is dynamically regulated in pluripotent stem cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24964274      PMCID: PMC4216477          DOI: 10.1089/scd.2013.0630

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  61 in total

Review 1.  New evidence for the insertion of mitochondrial DNA into the human genome: significance for cancer and aging.

Authors:  J W Shay; H Werbin
Journal:  Mutat Res       Date:  1992-09       Impact factor: 2.433

2.  Recurrent copy number variations in human induced pluripotent stem cells.

Authors:  Kristen Martins-Taylor; Benjamin S Nisler; Seth M Taapken; Tiwanna Compton; Leann Crandall; Karen Dyer Montgomery; Marc Lalande; Ren-He Xu
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

Review 3.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

Review 4.  A blueprint for engineering cell fate: current technologies to reprogram cell identity.

Authors:  Samantha A Morris; George Q Daley
Journal:  Cell Res       Date:  2013-01-01       Impact factor: 25.617

5.  Genome sequencing of mouse induced pluripotent stem cells reveals retroelement stability and infrequent DNA rearrangement during reprogramming.

Authors:  Aaron R Quinlan; Michael J Boland; Mitchell L Leibowitz; Svetlana Shumilina; Sidney M Pehrson; Kristin K Baldwin; Ira M Hall
Journal:  Cell Stem Cell       Date:  2011-10-04       Impact factor: 24.633

6.  Mouse major satellite DNA is prone to eccDNA formation via DNA Ligase IV-dependent pathway.

Authors:  Z Cohen; E Bacharach; S Lavi
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

7.  Genome integrity: linking pluripotency and tumorgenicity.

Authors:  Wenbin Deng; Yang Xu
Journal:  Trends Genet       Date:  2009-10-02       Impact factor: 11.639

8.  Accumulation of linear mitochondrial DNA fragments in the nucleus shortens the chronological life span of yeast.

Authors:  Xin Cheng; Andreas S Ivessa
Journal:  Eur J Cell Biol       Date:  2012-08-02       Impact factor: 4.492

9.  Somatic coding mutations in human induced pluripotent stem cells.

Authors:  Athurva Gore; Zhe Li; Ho-Lim Fung; Jessica E Young; Suneet Agarwal; Jessica Antosiewicz-Bourget; Isabel Canto; Alessandra Giorgetti; Mason A Israel; Evangelos Kiskinis; Je-Hyuk Lee; Yuin-Han Loh; Philip D Manos; Nuria Montserrat; Athanasia D Panopoulos; Sergio Ruiz; Melissa L Wilbert; Junying Yu; Ewen F Kirkness; Juan Carlos Izpisua Belmonte; Derrick J Rossi; James A Thomson; Kevin Eggan; George Q Daley; Lawrence S B Goldstein; Kun Zhang
Journal:  Nature       Date:  2011-03-03       Impact factor: 49.962

10.  Continued colonization of the human genome by mitochondrial DNA.

Authors:  Miria Ricchetti; Fredj Tekaia; Bernard Dujon
Journal:  PLoS Biol       Date:  2004-09-07       Impact factor: 8.029

View more
  3 in total

Review 1.  Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.

Authors:  Bhupendra Singh; Josephine S Modica-Napolitano; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-11       Impact factor: 15.707

2.  Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.

Authors:  Young Seok Ju; Jose M C Tubio; William Mifsud; Beiyuan Fu; Helen R Davies; Manasa Ramakrishna; Yilong Li; Lucy Yates; Gunes Gundem; Patrick S Tarpey; Sam Behjati; Elli Papaemmanuil; Sancha Martin; Anthony Fullam; Moritz Gerstung; Jyoti Nangalia; Anthony R Green; Carlos Caldas; Åke Borg; Andrew Tutt; Ming Ta Michael Lee; Laura J van't Veer; Benita K T Tan; Samuel Aparicio; Paul N Span; John W M Martens; Stian Knappskog; Anne Vincent-Salomon; Anne-Lise Børresen-Dale; Jórunn Erla Eyfjörd; Ola Myklebost; Adrienne M Flanagan; Christopher Foster; David E Neal; Colin Cooper; Rosalind Eeles; Steven G Bova; Sunil R Lakhani; Christine Desmedt; Gilles Thomas; Andrea L Richardson; Colin A Purdie; Alastair M Thompson; Ultan McDermott; Fengtang Yang; Serena Nik-Zainal; Peter J Campbell; Michael R Stratton
Journal:  Genome Res       Date:  2015-05-11       Impact factor: 9.043

3.  Mitochondria in the Nuclei of Rat Myocardial Cells.

Authors:  Chupalav M Eldarov; Irina M Vangely; Valeriya B Vays; Eugene V Sheval; Susanne Holtze; Thomas B Hildebrandt; Natalia G Kolosova; Vasily A Popkov; Egor Y Plotnikov; Dmitry B Zorov; Lora E Bakeeva; Vladimir P Skulachev
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.